1. Home
  2. VRA vs ANIX Comparison

VRA vs ANIX Comparison

Compare VRA & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vera Bradley Inc.

VRA

Vera Bradley Inc.

HOLD

Current Price

$3.37

Market Cap

117.4M

ML Signal

HOLD

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$2.77

Market Cap

100.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRA
ANIX
Founded
1982
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
117.4M
100.6M
IPO Year
2010
2013

Fundamental Metrics

Financial Performance
Metric
VRA
ANIX
Price
$3.37
$2.77
Analyst Decision
Hold
Strong Buy
Analyst Count
2
3
Target Price
N/A
$8.67
AVG Volume (30 Days)
155.9K
103.8K
Earning Date
06-10-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
20.47
12.82
EPS
N/A
N/A
Revenue
$416,097,000.00
$210,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2.50
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.39
$2.44
52 Week High
$4.39
$5.46

Technical Indicators

Market Signals
Indicator
VRA
ANIX
Relative Strength Index (RSI) 41.50 43.67
Support Level $2.35 $2.44
Resistance Level $3.80 $3.12
Average True Range (ATR) 0.21 0.13
MACD -0.08 -0.03
Stochastic Oscillator 20.09 32.65

Price Performance

Historical Comparison
VRA
ANIX

About VRA Vera Bradley Inc.

Vera Bradley Inc designs women's handbags, luggage, and travel items, fashion and home accessories, and gifts. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct and Vera Bradley Indirect.

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

Share on Social Networks: